| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 10, 2013
MINNEAPOLIS and DENVER - May 10, 2013 - Data presented today at Heart Rhythm 2013, the Heart Rhythm Society's 34th Annual Scientific Sessions, show that Medtronic, Inc. (NYSE:MDT) Lead Integrity...
-
May 10, 2013"Shock-Less" Late Breaking Clinical Trial: Providing Clinicians with ICD Programming Reports Improves Adherence to Evidence-Based Guidelines, Reduces All-Cause Shocks
MINNEAPOLIS and DENVER - May 10, 2013 -Validating its leadership in shock reduction research and technology, Medtronic, Inc. (NYSE: MDT) today announced the results of three clinical trials,...
-
Apr 29, 2013
MEMPHIS, TENN. - April 29, 2013- Medtronic, Inc. (NYSE: MDT) the world leader in spinal technology announced today the U.S. launch of several new product line additions to the VERTEX SELECT®...
-
Apr 29, 2013
MEMPHIS, TENN. - April 29, 2013- Medtronic, Inc. (NYSE: MDT) the world leader in spinal technology announced today the global launch of the MAST ALIGNEDSM procedure. This comprehensive surgical...
-
Mar 11, 2013ACC.13 Presentation Features Unprecedented Data on Nearly 5,000 Patients, Including "All Comers," from Global RESOLUTE Clinical Program
SAN FRANCISCO -- March 11, 2013 -- Cardiologists at ACC.13 learned today that patients with coronary artery disease who received a Resolute drug-eluting stent from Medtronic, Inc. (NYSE: MDT) as...
-
Mar 10, 201324-Month Clinical Update from Symplicity HTN-2 Presented Today at the 62nd Annual Scientific Session of the American College of Cardiology
MINNEAPOLIS and SAN FRANCISCO - March 10, 2013 - Medtronic, Inc. (NYSE: MDT) today announced 24-month data from Symplicity HTN-2, the first randomized clinical trial investigating renal...
-
Mar 4, 2013"Global Heroes" Will Receive Entry and Travel to the Medtronic Twin Cities Marathon or Medtronic TC 10 Mile in October
MINNEAPOLIS - March 4, 2013 - Medtronic, Inc. (NYSE: MDT) announced today it is recruiting runners from around the world who benefit from medical technology to participate in the eighth annual...
-
Feb 28, 2013
MINNEAPOLIS - Feb. 28, 2013 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Cowen and Company 33rd Annual Healthcare...
-
Feb 28, 2013New Valve Provides Transapical Option for Physicians Treating Patients with Aortic Stenosis
MINNEAPOLIS - February 28, 2013 - Medtronic, Inc. (NYSE: MDT) today announced CE (Conformité Européenne) Mark of the Engager Transcatheter Aortic Valve Implantation (TAVI) System with...
-
Feb 19, 2013Revenue of $4.0 Billion Grew 4% on a Constant Currency Basis; 3% as Reported
MINNEAPOLIS - February 19, 2013 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2013, which ended January 25, 2013. The Company reported...
-
Feb 3, 2013Rubio Helps Web Visitors Save a "Virtual" Life at HeartRescueNow.com
MINNEAPOLIS, February 5, 2013 -Minnesota Timberwolves basketball star Ricky Rubio joins the Medtronic Foundation this February in saving young lives worldwide from sudden cardiac arrest (SCA)....
-
Jan 30, 2013Strategic Alliance to Leverage Best of Both Companies to Reach Cardiovascular Patients in China and Other Emerging Markets
MINNEAPOLIS and Shenzhen - January 30, 2013 - Medtronic, Inc. (NYSE:MDT) and LifeTech Scientific Corporation (8122:HK) today announced the closing of a transaction creating a strategic alliance...
-
Jan 7, 2013
MINNEAPOLIS - January 7, 2013 - In a presentation to investors, Medtronic, Inc. (NYSE:MDT) today updated diluted earnings per share (EPS) guidance for fiscal year 2013. The Company tightened its...
-
Dec 12, 2012
MINNEAPOLIS - Dec 4, 2012 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Oppenheimer 23rd Annual Healthcare Conference on...
-
Dec 10, 2012
MINNEAPOLIS - Dec 10, 2012 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the JP Morgan 31st Annual Healthcare Conference on...
-
Dec 6, 2012
MEMPHIS, Tenn. - Dec. 6, 2012 - Medtronic, Inc. (NYSE: MDT) the world leader in spinal technology, announced the U.S. launch of the company's latest addition to their cervical surgical technique...
-
Nov 20, 2012Revenue of $4.1 Billion Grew 5% on a Constant Currency Basis; 2% as Reported
MINNEAPOLIS - November 20, 2012 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2013, which ended October 26, 2012. The Company reported...
-
Nov 1, 2012Accelerates Globalization and Company's Overall Position in Global Orthopedics Market
MINNEAPOLIS, Nov. 1, 2012 - Medtronic, Inc. (NYSE: MDT) announced today that it has completed its acquisition of China Kanghui Holdings (NYSE: KH), a leading provider of orthopedic devices in...
-
Oct 29, 2012Data Demonstrate High Procedural Success in Late-Breaking Trials Session at the European Association for Cardio-Thoracic Surgery Annual Meeting
MINNEAPOLIS - October 29, 2012 - Medtronic, Inc. (NYSE: MDT) today announced promising data from the EngagerTM European Pivotal Trial for the investigational Medtronic EngagerTM Transcatheter...
-
Oct 29, 2012Data Demonstrate High Procedural Success in Late-Breaking Trials Session at the European Association for Cardio-Thoracic Surgery Annual Meeting
MINNEAPOLIS - October 29, 2012 - Medtronic, Inc. (NYSE: MDT) today announced promising data from the EngagerTM European Pivotal Trial for the investigational Medtronic EngagerTM Transcatheter...
-
Oct 29, 2012Data Demonstrate High Procedural Success in Late-Breaking Trials Session at the European Association for Cardio-Thoracic Surgery Annual Meeting
MINNEAPOLIS - October 29, 2012 - Medtronic, Inc. (NYSE: MDT) today announced promising data from the EngagerTM European Pivotal Trial for the investigational Medtronic EngagerTM Transcatheter...
-
Sep 27, 2012Acquisition Advances Medtronic's Globalization Strategy; Provides Strong Local China Operation as well as Broader Orthopedics Participation
MINNEAPOLIS and CHANGZHOU, CHINA - Sept. 27, 2012 - Medtronic, Inc. (NYSE: MDT) and China Kanghui Holdings (NYSE: KH) announced today that they have entered into a merger agreement whereby...
-
Aug 21, 2012Revenue of $4.0 Billion Grew 5% on a Constant Currency Basis; 2% as Reported
MINNEAPOLIS - August 21, 2012 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2013, which ended July 27, 2012. The Company reported worldwide...
-
Jun 21, 2012
MINNEAPOLIS - June 21, 2012 - The board of directors of Medtronic, Inc. (NYSE: MDT) today approved a 7.2 percent increase in its cash dividend for fiscal year 2013, raising the quarterly amount to...
-
May 31, 2012
MINNEAPOLIS--(BUSINESS WIRE)--May. 31, 2012-- Medtronic, Inc. (NYSE: MDT), the world’s leading medical technology company, today announced it will participate in the Goldman Sachs 33rd Annual...
-
May 25, 2012Study Results Slated for Presentation in Late-Breaking Clinical Trials Session at Endocrinology Meeting Include Low Event Rates Through Two Years of Follow-Up
MINNEAPOLIS--(BUSINESS WIRE)--May. 25, 2012-- According to study results to be featured in Sunday’s late-breaking clinical trials session at the American Association of Clinical Endocrinologists...
-
May 22, 2012Revenue of $4.3 Billion Grew 4% on a Constant Currency Basis; 3% as Reported
MINNEAPOLIS--(BUSINESS WIRE)--May. 22, 2012-- Medtronic, Inc. (NYSE:MDT) today announced financial results for its fourth quarter and fiscal year ended April 27, 2012. The company reported...
-
May 11, 2012Study Reinforces Clinical and Economic Validity of Expanded Indication for Medtronic CRT-D Devices
MINNEAPOLIS & BOSTON--(BUSINESS WIRE)--May. 11, 2012-- Medtronic, Inc. (NYSE: MDT) today announced findings from an economic analysis of the landmark RAFT (Resynchronization / Defibrillation in...
-
May 10, 2012Late-Breaking Clinical Trial Validates Medtronic Proprietary Device Algorithms
MINNEAPOLIS & BOSTON--(BUSINESS WIRE)--May. 10, 2012-- Medtronic, Inc. (NYSE: MDT) today announced results from the first and only clinical trial to show that Medtronic cardiac devices can safely...
-
May 8, 2012Implantable Medical Device for Endovascular Repair of Thoracic Aortic Aneurysms Also Being Studied for Minimally Invasive Treatment of Blunt Thoracic Aortic Injuries
MINNEAPOLIS--(BUSINESS WIRE)--May. 8, 2012-- Increasing patient access to endovascular repair of aortic aneurysms worldwide, Medtronic, Inc. (NYSE: MDT) is expanding availability of the Valiant®...
-
Apr 27, 2012Six Month Pooled Outcomes From Randomized and Crossover Patients Following Renal Denervation Presented at the 22nd Annual Scientific Meeting of the European Society of Hypertension Confirm Previous Symplicity Clinical Trial Findings
MINNEAPOLIS & LONDON, Apr 27, 2012 (BUSINESS WIRE) --Medtronic, Inc., (NYSE: MDT), announced today six month pooled outcomes from randomized and crossover patients in the Symplicity HTN-2 clinical...
-
Mar 26, 2012ACC.12 Late-breaker Shows Promise of Pacemakers through Diminishing Fainting Recurrences in Patients Diagnosed with Syncope
MINNEAPOLIS & CHICAGO--(BUSINESS WIRE)--Mar. 26, 2012-- Medtronic, Inc. (NYSE: MDT) today announced the results of a double-blind, randomized study, ISSUE-3, which found that patients who suffered...
-
Mar 24, 2012Recently FDA-Approved, Novel Heart Device Shows Consistently Low Event Rates Across Broad Spectrum of Coronary Artery Disease Patients, Including Those with Diabetes
CHICAGO--(BUSINESS WIRE)--Mar. 24, 2012-- According to new clinical data presented today at ACC.12 –– the 61st Annual Scientific Session & Expo of the American College of Cardiology (ACC)...
-
Mar 24, 2012
MINNEAPOLIS--(BUSINESS WIRE)--Mar. 24, 2012-- Medtronic, Inc. (NYSE: MDT) today announced results from its largest international, prospective, single-arm clinical trial evaluating the Medtronic...
-
Mar 1, 2012“Global Heroes” Will Receive Entry and Travel to the Medtronic Twin Cities Marathon or Medtronic TC 10 Mile in October
MINNEAPOLIS--(BUSINESS WIRE)--Mar. 1, 2012-- Medtronic, Inc. (NYSE: MDT) announced today it is recruiting runners from around the world who benefit from medical technology to participate in the...
-
Jan 30, 2012Multicenter Experience Demonstrates Surgical Approach, with Recent CE Mark, is a Feasible Alternative for Transcatheter Aortic Valve Implantation
MINNEAPOLIS--(BUSINESS WIRE)--Jan. 30, 2012-- Medtronic, Inc. (NYSE: MDT) today issued a statement on the results of two studies evaluating the use of the Medtronic CoreValve® System delivered...
-
Jan 30, 2012Multicenter Experience Demonstrates Surgical Approach, with Recent CE Mark, is a Feasible Alternative for Transcatheter Aortic Valve Implantation
MINNEAPOLIS, Jan 30, 2012 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today issued a statement on the results of two studies evaluating the use of the Medtronic CoreValve(R) System delivered...
-
Dec 23, 2011
MINNEAPOLIS--(BUSINESS WIRE)--Dec. 23, 2011-- Medtronic, Inc. (NYSE: MDT), the world’s leading medical technology company, today announced it will participate in the 30th Annual JP Morgan...
-
Dec 9, 2011Neurostimulator with Innovative Motion Sensor Technology Was Recently Approved by the FDA for the Management of Chronic Pain
MINNEAPOLIS--(BUSINESS WIRE)--Dec. 9, 2011-- Clinical trial data presented at the 15th Annual Meeting of the North American Neuromodulation Society demonstrate the AdaptiveStim™ with...
-
Nov 17, 2011
MINNEAPOLIS & BOSTON--(BUSINESS WIRE)--Nov. 17, 2011-- Medtronic, Inc. (NYSE:MDT) and Bain Capital, a leading global private investment firm, today announced they have entered into a definitive...
-
Nov 8, 2011Pooled Data Analyses to Be Presented at TCT 2011 Demonstrate Heart Device's Consistently Positive Performance Across Multiple Clinical Studies
SAN FRANCISCO, Nov 08, 2011 (BUSINESS WIRE) -- Currently under review by the U.S. Food and Drug Administration (FDA), the Resolute(R) drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT)...
-
Nov 8, 2011Final Five-Year Follow-up of Randomized ENDEAVOR IV Trial Shows Durable Safety and Efficacy of Endeavor DES, with Comparatively Lower Rates of Cardiac Death/Myocardial Infarction and Very Late Stent Thrombosis
SAN FRANCISCO, Nov 08, 2011 (BUSINESS WIRE) -- New research findings released at TCT 2011 show that the Endeavor(R) zotarolimus-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT) outperformed...
-
Nov 4, 2011Presentations Cover Stents and Balloons for Coronary and Peripheral Artery Disease, Transcatheter Valve for Aortic Stenosis, Stent Grafts for Aortic Aneurysms, and Renal Denervation for Treatment-Resistant Hypertension and Heart Failure
MINNEAPOLIS, Nov 04, 2011 (BUSINESS WIRE) -- Offering the broadest range of medical technology for the interventional and surgical treatment of cardiovascular disease, Medtronic, Inc. (NYSE: MDT)...
-
Nov 3, 2011The latest advancement in expandable cage technology for surgeons, hospitals and patients
MEMPHIS, Tenn., Nov 03, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) announced the global launch of the T2 ALTITUDE(TM) Expandable Corpectomy Device in the U.S. and Europe today at the North...
-
Nov 2, 2011
MEMPHIS, Tenn., Nov 02, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) the world leader in spinal technology, announced today a pioneering approach to minimally invasive spinal fusion at the 26th
-
Nov 2, 2011
MINNEAPOLIS, Nov 02, 2011 (BUSINESS WIRE) -- To address surgeon needs of rapidly managing hemostasis in minimally invasive spine surgery, Medtronic, Inc. (NYSE: MDT) announced today the launch of...
-
Oct 26, 2011U.S. Clinical Trial of Symplicity(R) Renal Denervation System(TM) Enrolls First Patient
MINNEAPOLIS, Oct 26, 2011 (BUSINESS WIRE) -- Medtronic Inc. (NYSE: MDT) announced today the start of SYMPLICITY HTN-3, the company's U.S. clinical trial of the Symplicity(R) Renal Denervation...
-
Sep 12, 2011New technology offers one-source, customizable option for bone grafting space maintenance in oral-maxillofacial applications
MEMPHIS, Tenn., Sep 12, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) announced today the U.S. launch of its ARTISAN(TM) Space Maintenance System. The device is cleared for temporary use in...
-
Sep 8, 2011Index Acknowledge Corporate Sustainability Accomplishments
MINNEAPOLIS, Sep 08, 2011 (BUSINESS WIRE) -- Recognizing its leadership in meeting the needs of economic, environmental, and social stakeholders, Medtronic, Inc. (NYSE: MDT) has been named a...
-
Aug 31, 2011Medtronic Expands Role in Advanced Energy Surgical Technologies
MINNEAPOLIS, Aug 31, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has completed the acquisition of two privately-held companies, PEAK Surgical, Inc. and Salient...
-
Aug 5, 2011
MINNEAPOLIS, Aug 05, 2011 (BUSINESS WIRE) -- Medtronic investors and other interested parties are invited to participate in a live video webcast of the Medtronic Annual Shareholder Meeting on...
-
Jul 25, 2011Presented at CVIT by Principal Investigator Shigeru Saito, One-Year Data from RESOLUTE Japan Support Company's PMDA Submission for Product Approval
MINNEAPOLIS, Jul 25, 2011 (BUSINESS WIRE) -- TheResolute(R) drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT), showed superiority to Boston Scientific Corp.'s Taxus(R) DES on the primary...
-
Jul 11, 2011Patient Enrollment in U.S. Clinical Trial of Renal Denervation with Symplicity(R) Catheter System(TM) for Treating Resistant Hypertension to Start Soon
MINNEAPOLIS, Jul 11, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY...
-
Jul 7, 2011Medtronic Targets Leadership Role in Advanced Energy Surgical Technologies
MINNEAPOLIS, Jul 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire Salient Surgical Technologies, Inc., the leader...
-
Jul 7, 2011Medtronic Targets Leadership Role in Advanced Energy Surgical Technologies
MINNEAPOLIS, Jul 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire PEAK Surgical, Inc., a recognized leader in the...
-
Jun 23, 2011
MINNEAPOLIS, Jun 23, 2011 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE: MDT) today approved an eight percent increase in its cash dividend for fiscal year 2012, raising the...
-
Jun 18, 2011Innovative Medical Device Shows Strong Safety and Efficacy in Treatment of Thoracic Aortic Aneurysms Through One-Year of Patient Follow-Up in U.S. Clinical Study
MINNEAPOLIS & CHICAGO, Jun 18, 2011 (BUSINESS WIRE) -- An innovative medical device used in the minimally invasive treatment of thoracic aortic aneurysms, the Valiant(R) Thoracic Stent Graft...
-
Jun 3, 2011
MINNEAPOLIS, Jun 03, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 32nd annual Goldman Sachs...
-
May 24, 2011Record Fourth Quarter Revenue of $4.3 Billion Driven by Strong International Growth of 12%
MINNEAPOLIS, May 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its fourth quarter and fiscal year ended April 29, 2011. Medtronic recorded fiscal...
-
May 24, 2011
MINNEAPOLIS, May 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today provided its initial revenue outlook and diluted earnings per share (EPS) guidance for fiscal year 2012. The company...
-
May 5, 2011Results Provide Evidence Supporting Potential Expansion of Indications for CRT in Symptomatic, Permanent Atrial Fibrillation Patient Population
MINNEAPOLIS & SAN FRANCISCO, May 05, 2011 (BUSINESS WIRE) -- Data presented as a Late Breaking Clinical Trial at Heart Rhythm 2011, the Heart Rhythm Society's 32nd Annual Scientific Sessions,...
-
May 5, 2011
MINNEAPOLIS & SAN FRANCISCO, May 05, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced findings from the DISCERN AF trial, which utilized Medtronic's Reveal(R) XT insertable...
-
May 5, 2011New Leads Add to Company's Expansive Portfolio of Innovative CRT-Related Technology Proven to Treat Heart Failure Patients
MINNEAPOLIS & SAN FRANCISCO, May 05, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and launch of the Attain Ability(R)...
-
May 2, 2011New Technology Adds Diagnostic Capability to the Arctic Front(R) Cardiac CryoAblation Catheter System in Treating Paroxysmal Atrial Fibrillation
MINNEAPOLIS, May 02, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval for use, and the first patient procedure using the...
-
Apr 27, 2011Shareholders Invited to Attend Annual Meeting on Aug. 25, 2011
MINNEAPOLIS, Apr 27, 2011 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE: MDT), today announced that the company's annual meeting of shareholders will be held at 10:30 a.m.,...
-
Apr 4, 2011Across Spectrum of Patients with Coronary Artery Disease, Novel Heart Device Shows Strong Results at One Year in RESOLUTE US and Two Years in RESOLUTE All Comers
NEW ORLEANS, Apr 04, 2011 (BUSINESS WIRE) -- Results of two major clinical studies presented at ACC.11 - the 60th Annual Scientific Session & Expo of the American College of Cardiology (ACC) -...
-
Mar 28, 2011Late-Breaking Clinical Trials Feature One-Year Results of RESOLUTE US Study; Latest Evidence from Comprehensive Research Program Completes FDA Approval Submission
MINNEAPOLIS, Mar 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), today announced the imminent release of the pivotal U.S. data on its Resolute(R) drug-eluting stent (DES) at ACC.11, the 60th
-
Mar 11, 2011
MINNEAPOLIS, Mar 11, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the annual Barclays Capital 2011...
-
Mar 10, 2011Offering Surgeons An Additional Rod Material Option To Treat The Occipitocervical and Upper-Thoracic Spine
MEMPHIS, Tenn., Mar 10, 2011 (BUSINESS WIRE) -- Continuing its leadership in cervical spine medical device therapies, Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of VERTEX...
-
Mar 3, 2011"Global Heroes" Will Receive Entry and Travel to the Medtronic Twin Cities Marathon or Medtronic TC 10 Mile in October
MINNEAPOLIS, Mar 03, 2011 (BUSINESS WIRE) -- Medtronic (NYSE: MDT) announced today it is recruiting runners from around the world who benefit from medical technology to participate in the sixth...
-
Feb 25, 2011
MINNEAPOLIS, Feb 25, 2011 (BUSINESS WIRE) -- Medtronic, Inc.(NYSE: MDT) today announced that it has completed the purchase of rights to a chitosan-dextran gel technology from Adelaide Research &...
-
Feb 24, 2011
MINNEAPOLIS, Feb 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the annual Citi 2011 Global...
-
Jan 13, 2011Interventional Therapy Addresses Uncontrolled Hypertension with Renal Denervation
MINNEAPOLIS & MOUNTAIN VIEW, Calif., Jan 13, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), today announced that it has completed the acquisition of privately-held Ardian, Inc., a developer...
-
Jan 7, 2011
MINNEAPOLIS, Jan 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 29th annual J.P. Morgan...
-
Nov 22, 2010
MINNEAPOLIS & MOUNTAIN VIEW, Calif., Nov 22, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) and privately-held Ardian, Inc. announced today that they have entered into a merger agreement...
-
Nov 14, 2010RAFT Clinical Trial First to Show Significantly Reduced Mortality in Mildly Symptomatic Patients Study Has Longest Follow-Up and Largest Patient Months of Experience of Any CRT Therapy Study
MINNEAPOLIS & CHICAGO, Nov 14, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the landmark RAFT (Resynchronization/Defibrillation for Ambulatory Heart Failure Trial)...
-
Oct 6, 2010
MEMPHIS, Tenn., Oct 06, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the U.S. launch of the VERTEX SELECT(R) Reconstruction System Posted Screw Module. The announcement was...
-
Oct 5, 2010
MINNEAPOLIS, Oct 05, 2010 (BUSINESS WIRE) -- Medtronic Inc. (NYSE:MDT) today announced the launch of the new KYPHON(R) Express(TM) Curette for scraping or scoring bone in the spine, including...
-
Sep 23, 2010Announced at Clinton Global Initiative, an initial $1 million in grants are part of an overall strategic effort to reduce the burden of chronic disease
MINNEAPOLIS, Sep 23, 2010 (BUSINESS WIRE) -- Medtronic, Inc. today announced at the Clinton Global Initiative a $1 million commitment to the NCD Alliance. The grants are made in preparation for...
-
Sep 20, 2010Consistent Results in More Than 3,600 Patients from Complex Daily Practice of Interventional Cardiology Strengthen Evidence on Implantable Heart Device
WASHINGTON, Sep 22, 2010 (BUSINESS WIRE) -- Coronary artery disease, a leading cause of death and poor quality of life worldwide, runs the gamut from simple to complex, which complicates the daily...
-
Sep 13, 2010System Supports Proactive Patient Care for Patients at Risk for Worsening Heart Failure
MINNEAPOLIS, Sep 13, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today introduced the CareLink(R) Network for Heart Failure, an extension of the world's largest remote implantable cardiac...
-
Sep 13, 2010Medical Device Leader Recognized for Corporate Sustainability
MINNEAPOLIS, Sep 13, 2010 (BUSINESS WIRE) -- Recognizing its leadership in meeting the needs of economic, environmental, and social stakeholders, Medtronic, Inc. (NYSE: MDT) has been named a...
-
Sep 10, 2010"Innovating for a Better World" Reviews Company's Economic, Social and Environmental Performance for Fiscal Year 2010
MINNEAPOLIS, Sep 10, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) has released "Innovating for a Better World," the company's 2010 Corporate Citizenship Report. The online report, which...
-
Aug 24, 2010Updates Fiscal Year 2011 Revenue Outlook and EPS Guidance
MINNEAPOLIS, Aug 24, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2011, which ended July 30, 2010. The company reported...
-
Aug 17, 2010Acquisition Will Expand Product Offering, Pipeline and New Markets for Biologics Business
MEMPHIS, Tenn., Aug 17, 2010 (BUSINESS WIRE) -- Medtronic Inc., (NYSE: MDT) and Osteotech, Inc., (NASDAQ: OSTE) today announced that the companies have signed a definitive agreement under which...
-
Aug 16, 2010
MINNEAPOLIS, Aug 16, 2010 (BUSINESS WIRE) -- Medtronic investors and other interested parties are invited to participate in a live Webcast of the Medtronic Annual Shareholder Meeting on Wednesday,...
-
Jul 29, 2010Medtronic Launches Novel Clinical Trial Evaluating Spinal Cord Stimulation Therapy for Heart FailureDefeat-HF Trial Aims to Slow HF Progression with Neurostimulation
MINNEAPOLIS, Jul 29, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the global launch of the Defeat-HF (Determining the Feasibility of Spinal Cord Neuromodulation for the...
-
Jun 23, 2010
MINNEAPOLIS, Jun 23, 2010 (BUSINESS WIRE) --Gary Ellis, senior vice-president and chief financial officer at Medtronic, Inc. (NYSE: MDT) today reiterated fiscal year 2011 revenue and diluted...
-
Jun 10, 2010
MINNEAPOLIS, Jun 10, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 31st Annual Healthcare...
-
May 25, 2010International Revenue Growth of 20 Percent
MINNEAPOLIS, May 25, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT): First $4 Billion Sales Quarter in Company History Full Year Revenue of $15.8 Billion Increased 8 Percent Full Year Non-GAAP...
-
May 15, 2010Studies Presented at Heart Rhythm 2010 Demonstrate Advantages of Advanced Shock Reduction Technologies
MINNEAPOLIS & DENVER, May 15, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today released new data from the MVP (Managed Ventricular Pacing) trial that implantable defibrillator patients...
-
May 14, 2010Shareholders Invited to Attend Annual Meeting on Aug. 25, 2010
MINNEAPOLIS & DENVER, May 14, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today released new STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial data showing the...
-
May 14, 2010Trial Demonstrates Significant Decrease in Symptoms and Improved Quality of Life for AF Patients Treated with Arctic Front(R) Cardiac CryoAblation Catheter
MINNEAPOLIS & DENVER, May 14, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today released new STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial data showing the...
-
May 13, 2010New Medtronic Evidence on Shock Reduction Device Programming Strategies Released At Heart Rhythm 2010
MINNEAPOLIS & DENVER, May 13, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today released new evidence demonstrating that key shock-reduction programming strategies significantly reduced...
-
May 13, 2010Results of Virtual ICD Study Presented at Heart Rhythm 2010
MINNEAPOLIS & DENVER, May 13, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) released the Virtual ICD study data today that predicted 98 percent of studied implantable defibrillator patients...
-
Apr 29, 2010Acquisition Will Expand Access to Innovative Treatment Options for Structural Heart Disease
MINNEAPOLIS, Apr 29, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE:MDT), and ATS Medical, Inc. (NASDAQ:ATSI), today announced that the companies have signed a definitive agreement under which...
-
Mar 29, 2010InterStim Therapy for Bowel Control Currently Under Review by the U.S. FDA
MINNEAPOLIS, Mar 29, 2010 (BUSINESS WIRE) --Data published in the March issue of the Annals of Surgery show that investigational use of sacral nerve stimulation with Medtronic InterStim(R) Therapy...
-
Mar 19, 2010Positive Step Toward the First Pacemaker System Approval in the United States for Use in the MRI Environment
MINNEAPOLIS, Mar 19, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices...
-
Mar 18, 2010
MINNEAPOLIS, Mar 18, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that a landmark publication highlighting results from the pivotal study for Medtronic Deep Brain Stimulation...
-
Mar 17, 2010
MINNEAPOLIS, Mar 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced it has completed Pre-Market Approval (PMA) submission in consideration for U.S. Food and Drug...